Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3 - Metabolic Risk Factors Among Medicaid Outpatients With Schizophrenia Receiving Second-Generation Antipsychotics

Ryan C. Bell, Sharon Farmer, Richard Ries, and Debra Srebnik

Psychiatr Serv 60:1686-1689, December 2009

3 - Iloperidone: a new option for the treatment of schizophrenia

Andrew J Cutler

Expert Review of Neurotherapeutics. December 2009, Vol. 9, No. 12, Pages 1727-1741

 

3 - Olanzapine, not resperidone, exacerbates β-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them

Sunmin Park, Sang Mee Hong, Il Sung Ahn, and Sung Hoon Kim

Journal of Psychopharmacology. First published on December 4, 2009

3 - Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders

Alvin Liew, Swapna Verma, Lye Yin Poon, Abdin Edimansyah, Mythily Subramaniam, Janhavi Vaingankar, and Siow Ann Chong

Journal of Psychopharmacology. First published on December 4, 2009

3 - Adverse Endocrine and Metabolic Effects of Psychotropic Drugs: Selective Clinical Review

Bhuvaneswar, Chaya G; Baldessarini, Ross J; Harsh, Veronica L; Alpert, Jonathan E

CNS Drugs: 1 December 2009 - Volume 23 - Issue 12 - pp 1003-1021

 

3 - Effect of Aripiprazole on Cognition in the Treatment of Patients with Schizophrenia

M. Riedel, I. Spellmann, R. Schennach-Wolff, R. Musil, S. Dehning, A. Cerovecki, M. Opgen-Rhein, J. Matz, F. Seemüller, M. Obermeier, E. Severus, R. R. Engel, N. Müller, H.-J. Möller

Pharmacopsychiatry. Dec 2009 

5 - Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial

Mario Álvarez-Jiménez, Obdulia Martínez-García, Rocío Pérez-Iglesias, Mari Luz Ramírez, Jose Luis Vázquez-Barquero and Benedicto Crespo-Facorro

Schizophrenia Research. Volume 116, Issue 1, January 2010, Pages 16-19

 

3! - QTc interval in a sample of long-term schizophrenia inpatients

Ramón Ramos-Ríos, Manuel Arrojo-Romero, Eduardo Paz-Silva, Fernando Carballal-Calvo, José L. Bouzón-Barreiro, Jorge Seoane-Prado, Rosario Codesido-Barcala, Alicia Crespí-Armenteros, Ramón Fernández-Pérez, Javier D. López-Moríñigo, Ignacio Tortajada-Bonaselt, Francisco J. Diaz and Jose de Leon

Schizophrenia Research. Volume 116, Issue 1, January 2010, Pages 35-43

 

3! - The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study

John-Paul Nicolo, Gregor E. Berger, Belinda A. Garner, Dennis Velakoulis, Connie Markulev, Melissa Kerr, Patrick D. McGorry, Tina-Marie Proffitt, Mirabel McConchie, Christos Pantelis and Stephen J. Wood

Schizophrenia Research. Volume 116, Issue 1, January 2010, Pages 49-54

 

3!! - Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference?

Herng-Ching Lin, I-Ju Chen, Yi-Hua Chen, Hsin-Chien Lee and Fang-Jen Wu

Schizophrenia Research. Volume 116, Issue 1, January 2010, Pages 55-60

 

2 - Use of aripiprazole in tardive dyskinesia: An open label study of six cases

Rajaprabhakaran Rajarethinam;  John Dziuba;  Suzanne Manji;  Albert Pizzuti;  Leonard Lachover; Matcheri Keshavan

World Journal of Biological Psychiatry, Volume 10, Issue 5 December 2009, pages 416 - 419

 

3 - Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients

Young Sup Woo;  Won Kim;  Jeong-Ho Chae;  Bo-Hyun Yoon; Won-Myong Bahk

World Journal of Biological Psychiatry, Volume 10, Issue 5 December 2009, pages 420 - 425

 

3 - Prediction of symptom remission in schizophrenia during inpatient treatment

Markus Jager;  Michael Riedel;  Max Schmauss;  Gerd Laux;  Herbert Pfeiffer;  Dieter Naber;  Lutz G. Schmidt;  Wolfgang Gaebel;  Joachim Klosterkotter;  Isabella Heuser;  Kai-Uwe Kuhn;  Matthias R. Lemke;  Eckart Ruther;  Gerd Buchkremer;  Markus Gastpar;  Ronald Bottlender;  Anton Strauss; Hans-Jurgen Moller

World Journal of Biological Psychiatry, Volume 10, Issue 5 December 2009, pages 426 - 434

 

3! - A different hypothesis on hyponatremia in psychiatric patients: Treatment implications and experiences

Branimir Margetic; Branka Aukst-Margetic

World Journal of Biological Psychiatry, Volume 10, Issue 5 December 2009, pages 677 - 681

 

3 - Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT₆ and 5-HT_2A receptor mechanisms

Nagi Idris, Jo Neill, Ben Grayson, Benny Bang-Andersen, Louise M. Witten, Lise Tøttrup Brennum and Jørn Arnt

Psychopharmacology. Volume 208, Number 1 / January, 2010: 23-36

 

3 - Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice

David Delotterie, Geoffrey Ruiz, Jacques Brocard, Annie Schweitzer, Corinne Roucard, Yann Roche, Marie-Françoise Suaud-Chagny, Karine Bressand and Annie Andrieux

Psychopharmacology. Volume 208, Number 1 / January, 2010: 131-141

 

4 - Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms

Carla M. Canuso, Ibrahim Turkoz, John J. Sheehan and Cynthia A. Bossie

Journal of Affective Disorders. Volume 120, Issues 1-3, January 2010, Pages 193-199

 

4 - Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials

John M. Kane, Thomas R E Barnes, Christoph U Correll, Gary Sachs, Peter Buckley, James Eudicone, Robert McQuade, Quynh Van Tran, Andrei Pikalov III, and Sheila Assunção-Talbott

Journal of Psychopharmacology. First published on December 14, 2009

3! - Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

Bruce J Kinon, Lei Chen, Haya Ascher-Svanum, Virginia L Stauffer, Sara Kollack-Walker, Wei Zhou, Shitij Kapur and John M Kane

Neuropsychopharmacology (2010) 35, 581–590

 

5 - Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia

John M. Kane, Holland C. Detke, Dieter Naber, Gopalan Sethuraman, Daniel Y. Lin, Richard F. Bergstrom, and David McDonnell

Am J Psychiatry Published December 15, 2009

5 - Effects of Olanzapine and Risperidone on Glucose Metabolism and Insulin Sensitivity in Chronic Schizophrenic Patients With Long-Term Antipsychotic Treatment: A Randomized 5-Month Study

Robert C. Smith, Jean-Pierre Lindenmayer, John M. Davis, Erin Kelly, Thomas F. Viviano, James Cornwell, Qiaoyan Hu, Anzalee Khan, and Sumathi Vaidhyanathaswamy

J Clin Psychiatry 2009;70(11):1501–1513

 

3 - WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D₂ Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity

Julie A. Brennan, Radka Graf, Steven M. Grauer, Rachel L. Navarra, Claudine M. Pulicicchio, Zoë A. Hughes, Qian Lin, Caitlin Wantuch, Sharon Rosenzweig-Lipson, Farhana Pruthi, Margaret Lai, Deborah Smith, Wouter Goutier, Martina van de Neut, Albert J. Robichaud, David Rotella, Rolf W. Feenstra, Chris Kruse, Pierre Broqua, Chad E. Beyer, Andrew C. McCreary, Mark H. Pausch and Karen L. Marquis

JPET January 2010 vol. 332 no. 1 190-201

 

3! - Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking

Yuyan Jin, Bruce G. Pollock, Kim Coley, Del Miller, Stephen R. Marder, Jeff Florian, Lon Schneider, Jeffrey Lieberman, Margaret Kirshner, and Robert R. Bies

J Clin Pharmacol 2010;50(1):73

 

3 - Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters

David T. Chau, Danielle Gulick, Haiyi Xie, Ree Dawson and Alan I. Green

Neuropharmacology. Volume 58, Issue 2, February 2010, Pages 351-356

 

3! - Predictors of schizophrenia in patients with a first episode of psychosis

Nicolas Ramirez, Belen Arranz, Jose Salavert, Enrique Alvarez, Iluminada Corripio, Rosa Maria Dueñas, Victor Perez and Luis San

Psychiatry Research. Volume 175, Issues 1-2, 30 January 2010, Pages 11-14

 

3 - Attitudes towards long-acting depot antipsychotics: A survey of patients, relatives and psychiatrists

Matthias Jaeger and Wulf Rossler

Psychiatry Research. Volume 175, Issues 1-2, 30 January 2010, Pages 58-62

 

3! - The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment

Siegfried Kasper, Hans-Jürgen Möller and Anthony Hale

European Archives of Psychiatry and Clinical Neuroscience. Volume 260, Number 1 / February, 2010: 59-68

 

3! - Heritability of age of onset of psychosis in schizophrenia

Elizabeth Hare, David C. Glahn, Albana Dassori, Henriette Raventos, Humberto Nicolini, Alfonso Ontiveros, Rolando Medina, Rick Mendoza, Alvaro Jerez, Rodrigo Muñoz, Laura Almasy, Michael A. Escamilla

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Volume 153B Issue 1, Pages 298 - 302

 

3 - Effect of second-generation antipsychotics on cognition: current issues and future challenges

S Kristian Hill, Jeffrey R Bishop, Donna Palumbo and John A. Sweeney

Expert Review of Neurotherapeutics. January 2010, Vol. 10, No. 1, Pages 43-57

 

3 - Blonanserin: A Review of its Use in the Management of Schizophrenia

Deeks, Emma D; Keating, Gillian M

CNS Drugs: 1 January 2010 - Volume 24 - Issue 1 - pp 65-84

 

3 - Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety

Chris Hawley, Martin Turner, Muhammud A Latif, Vivienne Curtis, Packeruther T Saleem, Kristina Wilton

Human Psychopharmacology: Clinical and Experimental. Volume 25 Issue 1, Pages 37 - 46

 

3 - The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009

Julie Kreyenbuhl, Robert W. Buchanan, Faith B. Dickerson and Lisa B. Dixon

Schizophrenia Bulletin 2010 36(1):94-103

 

3! - Smoking in Schizophrenia: Diagnostic Specificity, Symptom Correlates, and Illness Severity

Roman Kotov, Lin T. Guey, Evelyn J. Bromet and Joseph E. Schwartz

Schizophrenia Bulletin 2010 36(1):173-181

 

3 - Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

R. Miller

 

Regresar a RESÚMENES DICIEMBRE 2009